전남대학교 중앙도서관

  • 중앙도서관
  • 여수캠퍼스도서관
  • 법학도서관
  • 치의학도서관
  • 의학도서관

링크메뉴

  • 화면키우기 화면줄이기 화면크기 원래대로
  • S
  • HOME
  • 로그인
  • 전남대
  • ENG
  • CHN

주메뉴

전체메뉴

전자자료 상세검색

전자자료 상세검색

통합검색
상세검색
검색어 [키워드: "JR. Berger"]
총 344건 
※ 중복 레코드가 제거된 검색 결과가 표시됩니다.
1/35 페이지 RSS 엑셀파일 출력
검색결과수정
  • 검색범위확장
    • Full Text내 키워드 확장
    • 관련 주제어 확장

    재검색

  • 검색결과제한
    • 원문(Full Text)
    • Peer-Reviewed 학술지
    • 발행년 -

    재검색

  • 자료유형
    • Academic Journals (344)

    재검색

  • 주제
    • leukoencephalopathy, progressive multifocal (69)
    • multiple sclerosis (38)
    • acquired immunodeficiency syndrome (35)

    더보기

    재검색

  • 간행물
    • neurology (58)
    • journal of neurovirology (29)
    • multiple sclerosis and related disorders (16)

    더보기

    재검색

  • 출판사
    • lippincott williams & wilkins (82)
    • springer (32)
    • elsevier (26)

    더보기

    재검색

  • 언어
    • english (344)

    재검색

  • 수록데이터베이스
    • MEDLINE (343)
    • Directory of Open Access Journals (1)

    재검색

  • PQDTSearch
  • CAJSearch
  • RISSSearch
  • PsycINFOSearch

 

4
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis. 미리보기

학술저널

issue
Current medical research and opinion [Curr Med Res Opin] 2023 Oct; Vol. 39 (10), pp. 1367-1374. Date of Electronic Publication: 2023 Sep 07.
Author
Butzkueven H; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.; The Alfred Hospital, Melbourne, VIC, Australia.
Hillert J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Soilu-Hänninen M; Turku University Hospital Neurocenter and Division of Clinical Neurosciences, University of Turku, Turku, Finland.
Ziemssen T; Center of Clinical Neuroscience, Department of Neurology, Dresden University of Technology, Dresden, Germany.
Kuhle J; Multiple Sclerosis Center and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
Wergeland S; Norwegian MS Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Magyari M; Danish Multiple Sclerosis Center and the Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Berger JR; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Moore N; Bordeaux PharmacoEpi (BPE), Université de Bordeaux, Bordeaux, France.
Aydemir A; EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA.
Bezemer I; Global Epidemiology, IQVIA, Amsterdam, The Netherlands.
Sabidó M; Merck Healthcare KGaA, Darmstadt, Germany.
DB Label
Database : MEDLINE
원문보기
Full Text (T&F Medical)  등재 - Web of Science (SCIE)  조회 - Impact Factor (JCR) 
5
Cancer Treatment in CKD: Time to Move Beyond Renalism. 미리보기

사설/의견

issue
Kidney360 [Kidney360] 2023 Sep 01; Vol. 4 (9), pp. e1193-e1195. Date of Electronic Publication: 2023 Sep 28.
Author
Berger JR; UT Southwestern: The University of Texas Southwestern Medical Center, Dallas, Texas.
Vazquez MA
DB Label
Database : MEDLINE
원문보기
Open Access (PubMed Central) 
6
Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis. 미리보기

학술저널

issue
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2023 Aug 10; Vol. 10 (5). Date of Electronic Publication: 2023 Aug 10 (Print Publication: 2023).
Author
Thebault S; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco. Dina.Jacobs2@pennmedicine.upenn.edu.
Gandelman S; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Lane C; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Kim EJ; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Pileggi C; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Zuroff L; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Yamashita LD; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Schindler MK; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Chiu C; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Wilson MR; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Berger JR; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Markowitz C; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Bar-Or A; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Fuller R; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Brandstadter R; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Pruitt AA; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
Jacobs DA; From the Division of Multiple Sclerosis (S.T., S.G., C.L., E.J.K., C.P., L.Z., L.D.Y., M.K.S., J.R.B., C.M., A.B.-O., R.F., R.B., A.A.P., D.A.J.), Hospital of the University of Pennsylvania and Perelman School of Medicine; Division of Infectious Diseases (C.C.), Department of Medicine; and Weill Institute for Neurosciences (M.R.W.), Department of Neurology, University of California, San Francisco.
DB Label
Database : MEDLINE
원문보기
Full Text (LWW - Ovid)  Open Access (PubMed Central)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
7
Total Tau Level in Cerebrospinal Fluid as a Predictor of Survival in Creutzfeldt-Jakob Disease: A Retrospective Analysis. 미리보기

학술저널

issue
Neurology. Clinical practice [Neurol Clin Pract] 2023 Jun; Vol. 13 (3), pp. e200161. Date of Electronic Publication: 2023 Apr 27.
Author
Coban H; Division of Multiple Sclerosis and Related Disorders (HC, JRB), Department of Neurology, Perelman School of Medicine at University of Pennsylvania; Perelman School of Medicine (PN), University of Pennsylvania; and Department of Biostatistics (DT, RS), Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, PA.
Nadella P; Division of Multiple Sclerosis and Related Disorders (HC, JRB), Department of Neurology, Perelman School of Medicine at University of Pennsylvania; Perelman School of Medicine (PN), University of Pennsylvania; and Department of Biostatistics (DT, RS), Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, PA.
Tu D; Division of Multiple Sclerosis and Related Disorders (HC, JRB), Department of Neurology, Perelman School of Medicine at University of Pennsylvania; Perelman School of Medicine (PN), University of Pennsylvania; and Department of Biostatistics (DT, RS), Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, PA.
Shinohara R; Division of Multiple Sclerosis and Related Disorders (HC, JRB), Department of Neurology, Perelman School of Medicine at University of Pennsylvania; Perelman School of Medicine (PN), University of Pennsylvania; and Department of Biostatistics (DT, RS), Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, PA.
Berger JR; Division of Multiple Sclerosis and Related Disorders (HC, JRB), Department of Neurology, Perelman School of Medicine at University of Pennsylvania; Perelman School of Medicine (PN), University of Pennsylvania; and Department of Biostatistics (DT, RS), Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, PA.
DB Label
Database : MEDLINE
원문보기
Full Text (LWW - Ovid)  Open Access (PubMed Central)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
9
Management approach including pembrolizumab for fingolimod-associated progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosis. 미리보기

학술저널

issue
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2023 Feb; Vol. 29 (2), pp. 301-306. Date of Electronic Publication: 2022 Nov 30.
Author
Barritt AW; Hurstwood Park Neurological Centre, Haywards Heath, UK/Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, Brighton, UK.
Das E; Hurstwood Park Neurological Centre, Haywards Heath, UK.
Morley N; Sussex Community NHS Foundation Trust, Brighton, UK.
Seymour M; Hurstwood Park Neurological Centre, Haywards Heath, UK.
Saha R; Hurstwood Park Neurological Centre, Haywards Heath, UK.
Vera J; Hurstwood Park Neurological Centre, Haywards Heath, UK/Department of Global Health and Infection, Brighton and Sussex Medical School, Brighton, UK.
Vundavalli S; Hurstwood Park Neurological Centre, Haywards Heath, UK.
Dizdarevic S; Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, Brighton, UK/Department of Nuclear Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Nicholas R; Department of Brain Sciences, Imperial College London, London, UK.
Berger JR; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Fisniku LK; Hurstwood Park Neurological Centre, Haywards Heath, UK/Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
DB Label
Database : MEDLINE
원문보기
등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
1 2 3 4 5  
바구니보기

QUICK LINK

  • 희망도서신청
  • 대출/연장조회
  • 서가부재도서
  • 이용교육

마이메뉴추가

QRCode
  • 개인정보호정책
  • 이메일무단수집거부
  • 도서관이용문의

    • 도서관자치위원회  원격제어  Instagram  facebook  w  kakao 플친
500-757 광주광역시 북구 용봉로 77 TEL 062)530-3571~2(대출반납실) FAX 062)530-3529
Copyright@2013 CHONNAM NATIONAL UNIVERSITY LIBRARY, All Rights Reserved.
  • 45309
  • 130605678